Home About Us Locations Disclaimer
Dr. R. deGoma
Finding The Cure
Who Needs Treatment
Benefits of Prevention
Are You At High Risk?
Coronary Calcium Score
Advanced Lipid Therapy
Medical Therapy vs Stent
Optimal vs Routine Tx
Our Performance Data
Million Hearts Center
Women's Heart Program
Chest Pain Clinic
Patient Mentoring
Adopting Healthy Habits
Our Practice Brochure

Education Programs

For Physicians:

PaKS Mentoring Program

For Communities:

Heart2Heart Talk

For Employers and Employees: Reducing Healthcare Cost

 

 

Relay Health

Contact Office for Non-Urgent Matters


 

Our mission since 2001:

Earlier detection...Stop disease progression...Improve patient outcomes...Reduce healthcare cost.

The highest level of care is the one that detects disease earlier and then applies evidence-based medical therapies to halt disease progression. For over a decade now, that has been the mission of Dr. R. deGoma at New Jersey Preventive Cardiology and Cholesterol Clinic. While prevention has only recently received the attention it truly deserves, we have already gained a decade of clinical expertise and have become better doing it. We developed an intelligent clinical management system to treat most high risk patients to goal and published a performance data in 2006. Truly, an ounce of prevention is worth a pound of cure. A daily dose of optimal medical treatment can prevent a $100,000 heart bypass, stent, heart attack, stroke and premature death three years later.

See how plaques cause heart attack and stroke and how evidence-based preventive medical therapy stops disease progression and prevents plaque rupture. Click this link to view:

Background: In 2001, Dr. R. deGoma had a conversion experience in the way he was practicing cardiology. Based on evolving medical science, he concluded that the future of cardiovascular disease management is more aggressive evidence-based preventive medical therapy, not more stents or more heart bypass. He decided to incorporate aggressive cardiovascular prevention as part of a routine cardiology visit. The L-TAP study published that year showed poor physician compliance with NCEP guidelines nationwide. It was a personal and professional journey that was featured in the Member Spotlight in the NLA Lipid Spin. He developed a numerically goal-oriented clinical management system and published a performance data in 2006. Event rate declined progressively and after three years, the interventionalist in their practice left. After a decade of aggressive evidence-based cardiovascular disease prevention, heart attacks and strokes have become rare occurrences.

 

The Present: The recent economic recession has put a spotlight on the percentage of GNP consumed by health care - actually, disease care mostly. Preventable cardiovascular disease is allowed to progress to advance stage because of several obstacles that can be overcome. Treatment of advance disease generates large revenues for the healthcare sector of the economy. There are no incentives to prevent most heart attacks and strokes while on the other hand, there is an overcapacity to treat them, like the many Stroke Centers waiting for people to have stroke. With the aging of the baby boomers, more heart attacks, strokes, heart failures, more hospitalizations, stents, heart bypass, devices may be a boon to this particular healthcare sector, but overall these avoidable expenditures are not sustainable and present a drag on the economy.

Supporters of The Million Hearts Initiative

 

Rolando deGoma, MD, FACC

Medical Director

NJ Preventive Cardiology & Cholesterol Clinic

Emil M. deGoma, MD, FACC

Medical Director

UPenn Preventive Cardiovascular  Program

 

Watch these Million Hearts Videos to Learn More

 

 

    
Capital Health Cardiology     www.deGomaMD.com     NJ Preventive Cardiology
Copyright 2001-2012     eMedical Consulting     All rights reserved     Preventing Most Heart Attacks and Strokes since 2001